ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $422,000 | -77.6% | 4,542 | -85.7% | 0.05% | -72.4% |
| Q3 2021 | $1,887,000 | +8.0% | 31,682 | +25.8% | 0.19% | -33.8% |
| Q1 2021 | $1,748,000 | +610.6% | 25,186 | +687.1% | 0.29% | +625.0% |
| Q4 2020 | $246,000 | -20.4% | 3,200 | -53.0% | 0.04% | +11.1% |
| Q4 2019 | $309,000 | +16.6% | 6,813 | +17.5% | 0.04% | 0.0% |
| Q3 2019 | $265,000 | -44.8% | 5,800 | -52.3% | 0.04% | +44.0% |
| Q1 2018 | $480,000 | +1.7% | 12,154 | -12.4% | 0.02% | -13.8% |
| Q4 2017 | $472,000 | -32.9% | 13,880 | -49.7% | 0.03% | -39.6% |
| Q3 2017 | $703,000 | -58.1% | 27,584 | -72.3% | 0.05% | -56.0% |
| Q2 2017 | $1,677,000 | – | 99,404 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |